Simulating non-small cell lung cancer with a multiscale agent-based model

[1]  Andrei Zinovyev,et al.  [Systems biology of cancer]. , 2009, Medecine sciences : M/S.

[2]  Daniel A. Haber,et al.  Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.

[3]  P. Bastiaens,et al.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.

[4]  Sean Martin,et al.  Advancing Cancer Systems Biology: Introducing the Center for the Development of a Virtual Tumor, CViT , 2007, Cancer informatics.

[5]  T. Deisboeck,et al.  Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. , 2006, Journal of theoretical biology.

[6]  G J Griffiths,et al.  Decreased internalisation of erbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib. , 2006, Systems biology.

[7]  T. Mok,et al.  Apoptosis induced by troglitazone is both peroxisome proliferator‐activated receptor‐γ‐ and ERK‐dependent in human non‐small lung cancer cells , 2006, Journal of cellular physiology.

[8]  D. Lauffenburger,et al.  Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.

[9]  Mike Holcombe,et al.  An integrated agent-mathematical model of the effect of intercellular signalling via the epidermal growth factor receptor on cell proliferation. , 2006, Journal of theoretical biology.

[10]  Barbara Di Ventura,et al.  From in vivo to in silico biology and back , 2006, Nature.

[11]  B. Zhivotovsky,et al.  Inhibitors of the PI3‐kinase/Akt pathway induce mitotic catastrophe in non‐small cell lung cancer cells , 2006, International journal of cancer.

[12]  M. Hendrix,et al.  Influence of the microenvironment on melanoma cell fate determination and phenotype. , 2006, Cancer research.

[13]  Stephanie Forrest,et al.  Modeling Somatic Evolution in Tumorigenesis , 2006, PLoS Comput. Biol..

[14]  S. McDougall,et al.  Mathematical modeling of tumor-induced angiogenesis. , 2006, Annual review of biomedical engineering.

[15]  G. Christofori New signals from the invasive front , 2006, Nature.

[16]  A. Chinnaiyan,et al.  Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. , 2006, Cancer research.

[17]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[18]  Thomas S Deisboeck,et al.  The effects of EGF-receptor density on multiscale tumor growth patterns. , 2005, Journal of theoretical biology.

[19]  A. Chinnaiyan,et al.  Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. , 2006, Cancer research.

[20]  Jeffrey Wyckoff,et al.  Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. , 2006, Cancer research.

[21]  G. Silvestri,et al.  Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. , 2005, Chest.

[22]  Ara A Vaporciyan,et al.  Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. , 2005, Radiology.

[23]  Manuel Hidalgo,et al.  Intracellular signal transduction pathway proteins as targets for cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Iyengar,et al.  Toward predictive models of mammalian cells. , 2005, Annual review of biophysics and biomolecular structure.

[25]  V. Boddi,et al.  Correlation of Epidermal Growth Factor Receptor Expression with Tumor Microdensity Vessels and with Vascular Endothelial Growth Factor Expression in Ovarian Carcinoma , 2005, International journal of surgical pathology.

[26]  Douglas A Lauffenburger,et al.  Ligand accumulation in autocrine cell cultures. , 2005, Biophysical journal.

[27]  Shinya Kuroda,et al.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.

[28]  Erik Sahai,et al.  Tumor cells caught in the act of invading: their strategy for enhanced cell motility. , 2005, Trends in cell biology.

[29]  John C. Doyle,et al.  Surviving heat shock: control strategies for robustness and performance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Lauffenburger,et al.  Parsing ERK Activation Reveals Quantitatively Equivalent Contributions from Epidermal Growth Factor Receptor and HER2 in Human Mammary Epithelial Cells* , 2005, Journal of Biological Chemistry.

[31]  Thomas S Deisboeck,et al.  Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors. , 2004, Journal of theoretical biology.

[32]  C. Nicholson,et al.  Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging. , 2004, Journal of neurophysiology.

[33]  Eric W. Su,et al.  Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer , 2004 .

[34]  G. Stamp,et al.  Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. , 2004, Neoplasia.

[35]  Francis Lin,et al.  Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. , 2004, Experimental cell research.

[36]  R. Eils,et al.  Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.

[37]  J. Condeelis,et al.  Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation , 2004, The Journal of cell biology.

[38]  P. Bunn,et al.  Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective. , 2004, International journal of radiation oncology, biology, physics.

[39]  S. Vicent,et al.  Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients , 2004, Clinical Cancer Research.

[40]  G. Tortora,et al.  The role of EGFR inhibitors in nonsmall cell lung cancer , 2004, Current opinion in oncology.

[41]  H. Othmer,et al.  Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.

[42]  Michael Lahn,et al.  Expression levels of protein kinase C-alpha in non-small-cell lung cancer. , 2004, Clinical lung cancer.

[43]  Amanda Y. Chan,et al.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism , 2004, Clinical & Experimental Metastasis.

[44]  D. Lauffenburger,et al.  Self-organization of polarized cell signaling via autocrine circuits: computational model analysis. , 2004, Biophysical journal.

[45]  D. Mukhopadhyay,et al.  Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration* , 2003, Journal of Biological Chemistry.

[46]  Chan Zeng,et al.  Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Thomas S Deisboeck,et al.  The impact of "search precision" in an agent-based tumor model. , 2003, Journal of theoretical biology.

[48]  H. Wiley,et al.  An integrated model of epidermal growth factor receptor trafficking and signal transduction. , 2003, Biophysical journal.

[49]  S. Kimura,et al.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. , 2003, The Biochemical journal.

[50]  F. Campbell,et al.  Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration , 2003, Journal of Cell Science.

[51]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[52]  Fengqin Gao,et al.  A Functional Role for Nicotine in Bcl2 Phosphorylation and Suppression of Apoptosis* , 2003, The Journal of Biological Chemistry.

[53]  Thomas S Deisboeck,et al.  Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model. , 2002, Journal of theoretical biology.

[54]  Stefano Iacobelli,et al.  The mechanism involved in the regulation of phospholipase Cγ1 activity in cell migration , 2002, Oncogene.

[55]  J. Brognard,et al.  Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants , 2002, Cell Death and Differentiation.

[56]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[57]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[58]  J. Minna,et al.  Molecular pathogenesis of lung cancer. , 1994, Annual review of physiology.

[59]  J. Brognard,et al.  Brognard J, Dennis PVariable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ 9: 893-904 , 2002 .

[60]  D A Lauffenburger,et al.  Spatial range of autocrine signaling: modeling and computational analysis. , 2001, Biophysical journal.

[61]  S. Torquato,et al.  Pattern of self‐organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model , 2001, Cell proliferation.

[62]  R. Iyengar,et al.  Signaling Networks The Origins of Cellular Multitasking , 2000, Cell.

[63]  C. Dang,et al.  Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Fell,et al.  Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells , 2000, FEBS letters.

[65]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[66]  A. Ullrich,et al.  Epidermal growth factor receptors: critical mediators of multiple receptor pathways. , 1999, Current opinion in cell biology.

[67]  U. Bhalla,et al.  Emergent properties of networks of biological signaling pathways. , 1999, Science.

[68]  E. Dmitrovsky,et al.  Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[69]  K. Fang,et al.  An enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell line. , 1996, British Journal of Cancer.

[70]  N. Haites,et al.  Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. , 1996, European journal of cancer.

[71]  L. Ellis,et al.  Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[73]  E. Dmitrovsky,et al.  Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. , 1993, Cancer research.

[74]  A. Gazdar,et al.  Autocrine growth stimulation by transforming growth factor-α in human non-small cell lung cancer , 1992 .

[75]  J. Roth,et al.  Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer. , 1992, Surgical oncology.

[76]  M. Inoue,et al.  in Vitro Ovarian Cancer Cell Line Growth Factor Receptor Autocrine Growth Mechanism in an / Epidermal α Involvement of Transforming Growth Factor , 2006 .

[77]  H. Kurachi,et al.  Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo. , 1991, Cancer research.

[78]  J. Freyer,et al.  Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply. , 1986, Cancer research.